Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017)

Adma Biologics' Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $245000.0 for Q2 2017.

For Q2 2017, Change in Acquisitions & Divestments rose 106.67% year-over-year to $245000.0; the TTM value through Mar 2018 reached $245000.0, down 98.65%, while the annual FY2017 figure was $5.4 million, 67.64% down from the prior year.
Change in Acquisitions & Divestments reached $245000.0 in Q2 2017 per ADMA's latest filing, down from $5.1 million in the prior quarter.
In the past five years, Change in Acquisitions & Divestments ranged from a high of $16.7 million in Q4 2016 to a low of -$3.7 million in Q2 2016.